Rank Tests and a One-Sample Logrank Test for Comparing Observed Survival Data to a Standard Population

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Biometrics

• Publication date

  1981-12-01

• Fields of study

  Mathematics

• Identifiers
  DOI 10.2307/2530150
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Testing to Determine the Underlying Distribution Using Randomly Censored Data.

  1979cited by this paper
• Comparing observed life table data with a known survival curve in the presence of random censorship

  1979cited by this paper
• A likelihood ratio statistic for testing goodness of fit with randomly censored data.

  1978cited by this paper
• Linear rank tests with right censored data

  1978influential reference
• Testing survival under right censoring and left truncation

  1977cited by this paper
• Mortality in Patients with Schizophrenia, Mania, Depression and Surgical Conditions

  1977cited by this paper
• A Cramér-von Mises statistic for randomly censored data

  1976cited by this paper
• Analysis of Survival Data under the Proportional Hazards Model

  1975cited by this paper
• Nonparametric methods in multivariate analysis

  1974cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper
• Asymptotically Efficient Rank Invariant Test Procedures

  1972cited by this paper
• Family studies in systemic lupus erythematosus—II

  1970cited by this paper
• The two sample problem with censored data

  1967cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966influential reference
• One Sample Limits of Some Two-Sample Rank Tests

  1964cited by this paper
• CONTRIBUTIONS TO THE THEORY OF RANK ORDER STATISTICS THE TWO SAMPLE CASE: FINE STRUCTURE OF THE ORDERING OF PROBABILITIES OF RANK ORDERS

  1956cited by this paper

• Drawing the Line: From U-Net-Based Glioblastoma Segmentation to Machine Learning-Driven Survival Prediction

  2026cites this paper
• Ionic and Non-Ionic Counterparts Based on Bis(Uracilyl)Alkane Moiety with Highest Selectivity Towards Acetylcholinesterase for Protection Against Organophosphate Poisoning and Treating Alzheimer’s Disease

  2025cites this paper
• One-sample survival tests in the presence of non-proportional hazards in oncology clinical trial

  2025cites this paper
• A new probability Chen model: Properties, risk analysis and distributions validation for testing using the right censored real data

  2025cites this paper
• Survival Model of Cervical Cancer Patients using the 3-Parameter Weibull Distribution Model

  2025cites this paper
• AI-driven predictive biomarker discovery with contrastive learning to improve clinical trial outcomes.

  2025cites this paper
• AI-based predictive biomarker discovery via contrastive learning retrospectively improves clinical trial outcome

  2024cites this paper
• A family of tests for trend change in failure rate function with right censored data

  2023cites this paper
• Risks for death after admission to pediatric intensive care 2 (PICU) - a comparison with the general population

  2022cites this paper
• Risks for death after admission to pediatric intensive care (PICU)—A comparison with the general population

  2022cites this paper
• Confidence intervals of mean residual life function in length-biased sampling based on modified empirical likelihood

  2022cites this paper
• Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321)

  2022cites this paper
• Phase 1/2 Trial of Vorinostat and Radiation and Maintenance Vorinostat in Children with Diffuse Intrinsic Pontine Glioma: A Children's Oncology Group Report.

  2021cites this paper
• An Investigation of Point Mutations Discovers Novel Genes and Their Corresponding Motifs in Pancreatic Cancer

  2021cites this paper
• Whole-Genome Analysis of De Novo Somatic Point Mutations Reveals Novel Mutational Biomarkers in Pancreatic Cancer

  2021cites this paper
• A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high‐grade glioma

  2020cites this paper
• Introduction to BGPhazard

  2020cites this paper
• Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis

  2020cites this paper
• A New Log-Logistic Lifetime Model with Mathematical Properties, Copula, Modified Goodness-of-Fit Test for Validation and Real Data Modeling

  2020cites this paper
• An improved one-sample log-rank test

  2020cites this paper
• Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.

  2019cites this paper
• Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials

  2019cites this paper
• Survival Models on Breast Cancer Patients-A Cross Sectional Data from the Ocean Road Cancer Institute (ORCI)

  2019cites this paper
• Children’s Oncology Group (COG) Trials for Retinoblastoma

  2019cites this paper
• Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis

  2018cites this paper
• Phase II Trials for Heterogeneous Patient Populations with a Time-to-Event Endpoint.

  2017cites this paper
• Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631.

  2017cites this paper
• A two-stage design for phase II trials with time-to-event endpoint using restricted follow-up

  2017cites this paper
• Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.

  2017cites this paper
• Single-Arm Phase II Survival Trial Design Under the Proportional Hazards Model

  2017cites this paper
• Single-arm Phase II cancer survival trial designs

  2016cites this paper
• Cure Rate Models

  2016cites this paper
• Differentiated Thyroid Cancer Patients More Than 60 Years Old Paradoxically Show an Increased Life Expectancy

  2015cites this paper
• Sample size calculation for the one‐sample log‐rank test

  2015cites this paper
• Sample size calculation for the one‐sample log‐rank test

  2015cites this paper
• Surveillance after initial surgery for Stage I pediatric and adolescent boys with malignant testicular germ cell tumors: Report from the Children's Oncology Group.

  2014cites this paper
• Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group.

  2014cites this paper
• One‐stage and two‐stage designs for phase II clinical trials with survival endpoints

  2014cites this paper
• Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT‐751: A report from the Children's Oncology Group (ANBL0621)

  2014cites this paper
• A New One-Sample Log-Rank Test

  2014cites this paper
• Peace of mind for patients with differentiated thyroid cancer?

  2013cites this paper
• Safety and efficacy of high‐dose tamoxifen and sulindac for desmoid tumor in children: Results of a Children's Oncology Group (COG) Phase II Study

  2013cites this paper
• Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia.

  2013cites this paper
• Children's Oncology Group's 2013 blueprint for research: Rare tumors

  2013cites this paper
• Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients.

  2013cites this paper
• A minimum version of log‐rank test for testing the existence of cancer cure using relative survival data

  2012influential citation
• A Note on Importance Resampling for Multi-Dimensional Statistics

  2011cites this paper
• Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group.

  2011cites this paper
• In PSC with Colitis Treated with UDCA, Most Colonic Carcinomas Develop in the First Years After the Start of Treatment

  2011cites this paper
• Establishing a follow-up of the Swiss MONICA participants (1984-1993): record linkage with census and mortality data

  2010cites this paper
• In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival.

  2010cites this paper
• A Parametric Quantile Regression Model Useful in Reliability Analysis

  2010influential citation
• A Mass Redistribution Algorithm for Right Censored and Left Truncated Time to Event Data.

  2009cites this paper
• Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis.

  2009cites this paper
• Überprüfung der im Rahmen des „Lebenserwartungssurveys“ gemessenen Sterblichkeit auf Bevölkerungsrepräsentativität unter Berücksichtigung rechts- und intervallzensierter Ereignisse mit dem Konzept „Relative Survival“

  2008cites this paper
• SURVIVAL ANALYSIS OF CANCER PATIENTS USING PARAMETRIC AND NON-PARAMETRIC APPROACHES

  2007cites this paper
• The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid

  2007cites this paper
• Linear Rank Tests in Survival Analysis

  2005cites this paper
• Survival of Anti-Mitochondrial Antibody-Positive and -Negative Primary Biliary Cirrhosis Patients on Ursodeoxycholic Acid Treatment

  2004cites this paper
• Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment.

  2002cites this paper
• CHAPMAN & HALL/CRC Texts in Statistical Science Series

  2002cites this paper
• Markov beta and gamma processes for modelling hazard rates

  2002cites this paper
• Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?

  1999cites this paper
• Ten‐year survival in ursodeoxycholic acid–treated patients with primary biliary cirrhosis

  1999cites this paper
• Nonparametric estimation of the survival function from censored data based on relative risk function

  1998cites this paper
• Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study.

  1997cites this paper
• A Bartlett-type correction for the subject-years method in comparing survival data to a standard population

  1996cites this paper
• KMT‐type inequalities and goodness‐of‐fit tests

  1994cites this paper
• Computation of Expected Deaths for Prediction and for Long-Term Follow-up Studies

  1986cites this paper
• Calculating expected mortality.

  1986cites this paper
• Simple nonparametric tests for a known standard survival based on censored data

  1985cites this paper
• 27 Nonparametric concepts and methods in reliability

  1984cites this paper
• The analysis of mortality by the subject-years method.

  1983cites this paper
• Comparing survival distributions: a review for nonstatisticians. I.

  1983cites this paper
• A class of rank test procedures for censored survival data

  1982cites this paper